Martha Hamilton, Investigational Drug Services, Dept of Pharmacy — Stanford, California

Martha Hamilton, Investigational Drug Services, Dept of Pharmacy is a clinical research site located in Stanford, California, United States 94305.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Martha Hamilton, Investigational Drug Services, Dept of Pharmacy has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stanford

Browse all research sites in California · View every site in Stanford

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Martha Hamilton, Investigational Drug Services, Dept of Pharmacy?

Martha Hamilton, Investigational Drug Services, Dept of Pharmacy has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Martha Hamilton, Investigational Drug Services, Dept of Pharmacy conducted?

Martha Hamilton, Investigational Drug Services, Dept of Pharmacy has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia.

Is Martha Hamilton, Investigational Drug Services, Dept of Pharmacy accredited by Crixeo Clinical Trials?

Martha Hamilton, Investigational Drug Services, Dept of Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Martha Hamilton, Investigational Drug Services, Dept of Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.